The Cerebral Palsy Foundation (CPF) is seeking out people with certain types of cerebral palsy to take part in a new clinical drug trial.
In a Feb. 1 announcement, CPF said the trial is aimed at people with dyskinetic cerebral palsy, which is marked by various types of involuntary movements.
The types of movements targeted by the drug trial are dystonia (defined as twisting, repetitive movements and postures); athetosis (slow, writhing movements); and chorea (abrupt, jerky, or irregular movements).
“Dyskinetic cerebral palsy is much more common than previously believed and can coexist with other types of cerebral palsy, such as spastic diplegia or quadriplegia,” the announcement said. “There is a recently started clinical drug trial being conducted at sites across the United States, testing a drug to see if it has an effect on involuntary movements that are difficult to control.”
People interested in learning more about the trial can contact CPF’s Jen Lyman at [email protected].
